Account
Inquiry
Tirzepatide (CAS 2023788-19-2) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes and weight management research. This white peptide powder has demonstrated superior efficacy in clinical trials compared to selective GLP-1 agonists.
As a research chemical, tirzepatide offers significant potential for metabolic studies. Clinical data from SURMOUNT-1 trials showed average weight reduction of 15-20.9% after 72 weeks at different dosages. The molecule features PEG modification for enhanced water solubility and combines the effects of two incretin hormones in a single molecule.
For researchers wondering where to buy tirzepatide, we offer pharmaceutical grade material in convenient 10mg vials (10 vials/box). Each batch undergoes rigorous quality control to ensure 99.9% purity. The peptide is particularly valuable for studies on glucose metabolism, obesity mechanisms, and novel diabetes treatments.
Storage recommendations: Keep tirzepatide in a cool, dry environment protected from light. Avoid repeated freeze-thaw cycles and prolonged exposure to air. For long-term stability, store lyophilized powder at -20°C.
Note: This product is intended for research purposes only. Not for human consumption or diagnostic use. Researchers should handle all peptides following appropriate laboratory safety protocols.
